These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

347 related items for PubMed ID: 1355468

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Current therapeutic possibilities in chronic inflammatory intestinal diseases].
    Schölmerich J.
    Praxis (Bern 1994); 1995 Jan 10; 84(2):29-33. PubMed ID: 7839043
    [Abstract] [Full Text] [Related]

  • 4. Drug insight: aminosalicylates for the treatment of IBD.
    Nielsen OH, Munck LK.
    Nat Clin Pract Gastroenterol Hepatol; 2007 Mar 10; 4(3):160-70. PubMed ID: 17339853
    [Abstract] [Full Text] [Related]

  • 5. Mesalamine and olsalazine: 5-aminosalicylic acid agents for the treatment of inflammatory bowel disease.
    Segars LW, Gales BJ.
    Clin Pharm; 1992 Jun 10; 11(6):514-28. PubMed ID: 1600685
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Refractory distal ulcerative colitis responsive to 5-aminosalicylate enemas.
    Barber GB, Lee DE, Antonioli DA, Peppercorn MA.
    Am J Gastroenterol; 1985 Aug 10; 80(8):612-4. PubMed ID: 2862789
    [Abstract] [Full Text] [Related]

  • 8. Review article: aminosalicylates in inflammatory bowel disease.
    Hanauer SB.
    Aliment Pharmacol Ther; 2004 Oct 10; 20 Suppl 4():60-5. PubMed ID: 15352896
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Sulphasalazine in inflammatory bowel disease: recent advances.
    Cooper BT.
    N Z Med J; 1986 Oct 08; 99(811):757-9. PubMed ID: 2877428
    [No Abstract] [Full Text] [Related]

  • 11. Medical treatment of inflammatory bowel disease: new therapies, new drugs.
    Sutherland LR.
    CMAJ; 1987 Nov 01; 137(9):799-802. PubMed ID: 2894889
    [Abstract] [Full Text] [Related]

  • 12. Sulfasalazine and new analogues.
    Friedman G.
    Am J Gastroenterol; 1986 Feb 01; 81(2):141-4. PubMed ID: 2868653
    [No Abstract] [Full Text] [Related]

  • 13. Therapeutic efficacy of sulfasalazine and its metabolites in patients with ulcerative colitis and Crohn's disease.
    Klotz U, Maier K, Fischer C, Heinkel K.
    N Engl J Med; 1980 Dec 25; 303(26):1499-502. PubMed ID: 6107853
    [Abstract] [Full Text] [Related]

  • 14. Chemistry, pharmacology, pharmacokinetics, and clinical applications of mesalamine for the treatment of inflammatory bowel disease.
    Small RE, Schraa CC.
    Pharmacotherapy; 1994 Dec 25; 14(4):385-98. PubMed ID: 7937276
    [Abstract] [Full Text] [Related]

  • 15. The short- and long-term safety of 5-aminosalicylate products in the treatment of ulcerative colitis.
    Baker DE, Kane S.
    Rev Gastroenterol Disord; 2004 Dec 25; 4(2):86-91. PubMed ID: 15185719
    [Abstract] [Full Text] [Related]

  • 16. [Therapeutic efficacy of 5-ASA molecules in idiopathic intestinal inflammatory diseases: critical review].
    Van Gossum A.
    Acta Gastroenterol Belg; 1992 Dec 25; 55(5-6):462-71. PubMed ID: 1363167
    [Abstract] [Full Text] [Related]

  • 17. New oral salicylates in the therapy of chronic idiopathic inflammatory bowel disease.
    Robinson MG.
    Gastroenterol Clin North Am; 1989 Mar 25; 18(1):43-50. PubMed ID: 2646221
    [Abstract] [Full Text] [Related]

  • 18. [Conservative therapy of ulcerative colitis and Crohn disease].
    Rasenack J, Kreisel W.
    Fortschr Med; 1991 Apr 10; 109(11):245-7. PubMed ID: 1855750
    [Abstract] [Full Text] [Related]

  • 19. Pharmacotherapy of inflammatory bowel disease. Part 1. Sulfasalazine.
    Das KM.
    Postgrad Med; 1983 Dec 10; 74(6):141-8, 150-1. PubMed ID: 6139795
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.